Mr Paul Osborne Watson, OTR/LMT in Ozark, AL - Massage Therapist

Mr Paul Osborne Watson, OTR/LMT is a Massage Therapist based in Ozark, Alabama. Mr Paul Osborne Watson is licensed to practice in Alabama (license number 5456) and his current practice location is 1394 S Us Highway 231 Ste 1, Ozark, Alabama. He can be reached at his office (for appointments etc.) via phone at (334) 443-1004.

NPI number for Mr Paul Osborne Watson is 1376791079 and his current mailing address is 1394 S Us Highway 231 Ste 1, Ozark, Alabama. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1376791079.

Contact Information

	Mr Paul Osborne Watson, OTR/LMT
	1394 S Us Highway 231 Ste 1, Ozark, AL 36360-4412
	(334) 443-1004
	Not Available

Healthcare Provider's Profile

Full Name	Mr Paul Osborne Watson
Gender	Male
Speciality	Massage Therapist
Location	1394 S Us Highway 231 Ste 1, Ozark, Alabama
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1376791079
Provider Enumeration Date: 09/05/2008
Last Update Date: 09/06/2023

Medical Identifiers

Medical identifiers for Mr Paul Osborne Watson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1376791079	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225X00000X	Occupational Therapist	5880 (Alabama)	Secondary
225700000X	Massage Therapist	5456 (Alabama)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Paul Osborne Watson is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Paul Osborne Watson, OTR/LMT 1394 S Us Highway 231 Ste 1, Ozark, AL 36360-4412 Ph: (334) 618-1494	Mr Paul Osborne Watson, OTR/LMT 1394 S Us Highway 231 Ste 1, Ozark, AL 36360-4412 Ph: (334) 443-1004

News Archive

New protocol for the study of SARS-CoV-2's medium and long-term outcomes

The clinical symptoms of the severe COVID-19 have been well described. In addition, scientists have defined the post-acute COVID-19 as the development of sequelae or persistence of symptoms several weeks after the onset of COVID-19 symptoms. In some cases, the symptoms persist for around 3-4 weeks, and in other cases of chronic COVID-19, symptoms may persist beyond 12 weeks from the onset of symptoms.

Keryx Biopharmaceuticals commences Phase 3 registration clinical trial for perifosine

Keryx Biopharmaceuticals, Inc. announced today the initiation of a Phase 3 registration clinical trial for KRX-0401 (perifosine), the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, for the treatment of patients with refractory advanced colorectal cancer.

New Web-based tool for tracking blood safety

The Georgia Tech College of Computing, working in partnership with the Centers for Disease Control and Prevention, has developed a Web-based tool for tracking blood safety.

Philadelphia diet drug trial completed

Wyeth has announced that the jury in the case of Rhonda Istnick and Henry Clepper v. Wyeth, et al. rendered its decision, finding in favor of the Company in the case brought by Ms. Istnick, while awarding Mr. Clepper compensatory damages in the amount of $48,000.

Mr Paul Osborne Watson, OTR/LMT - in Ozark, AL